GGrantIndex
← Leaderboards

Douglas Lowell Mann

Baylor College Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$13,049,987
Attributed
$14,816,426
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2005–22
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$21,493,030 · 10
VA$0 · 1

By mechanism

P50$7,416,456 · 2
R01$6,222,624 · 5
U10$3,532,879 · 1
T32$3,065,171 · 1
P01$1,255,900 · 1
I01$0 · 1

Top collaborators

Most similar at Baylor College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Heart Failure”

Research focus

Heart FailureInflammationCardiac MyocytesCardiovascular SystemLaboratory MouseMediatingOxidative StressPathway InteractionsLeftLeadResponseTumor Necrosis Factor AlphaHeartGenetically Modified AnimalsApoptosisMyocardialSeriesAcuteSignal PathwaySignal TransductionCytokineCardiacCytoprotectionInjury

Grant awards (52)

Autophagy in Myocardial Recovery and Remission$0
I01 · FY2022 · VA · contact PI
Autophagy in Myocardial Recovery and Remission$0
I01 · FY2021 · VA · contact PI
Autophagy in Myocardial Recovery and Remission$0
I01 · FY2020 · VA · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2018 · HL · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2017 · HL · contact PI
Principles in Cardiovascular Research Training Program$437,275
T32 · FY2017 · HL · contact PI
Principles in Cardiovascular Research Training Program$7,545
T32 · FY2017 · HL · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2016 · HL · contact PI
Principles in Cardiovascular Research Training Program$430,237
T32 · FY2016 · HL · contact PI
CYTOPROTECTIVE EFFECTS OF INFLAMMATION MEDIATED MEMBRANE REPAIR$387,490
R01 · FY2016 · HL · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2015 · HL · contact PI
CYTOPROTECTIVE EFFECTS OF INFLAMMATION MEDIATED MEMBRANE REPAIR$394,482
R01 · FY2015 · HL · contact PI
Principles In Cardiovascular Research Training Program$263,599
T32 · FY2015 · HL · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$502,354
U10 · FY2014 · HL · contact PI
Principles In Cardiovascular Research Training Program$411,731
T32 · FY2014 · HL · contact PI
CYTOPROTECTIVE EFFECTS OF INFLAMMATION MEDIATED MEMBRANE REPAIR$372,400
R01 · FY2014 · HL · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$510,602
U10 · FY2013 · HL · contact PI
Principles In Cardiovascular Research Training Program$402,730
T32 · FY2013 · HL · contact PI
CYTOPROTECTIVE EFFECTS OF INFLAMMATION MEDIATED MEMBRANE REPAIR$361,760
R01 · FY2013 · HL · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$515,991
U10 · FY2012 · HL · contact PI
Principles in Cardiovascular Research Training Program$402,730
T32 · FY2012 · HL · contact PI
CYTOPROTECTIVE EFFECTS OF INFLAMMATION MEDIATED MEMBRANE REPAIR$380,000
R01 · FY2012 · HL · contact PI
Principles in Cardiovascular Research Training Program$397,112
T32 · FY2011 · HL · contact PI
Cytoprotective Cytokine Signaling and Reperfusion Injury$386,636
R01 · FY2010 · HL · contact PI
Principles in Cardiovascular Research Training Program$312,212
T32 · FY2010 · HL · contact PI
Cytoprotective Cytokine Signaling and Reperfusion Injury$392,147
R01 · FY2009 · HL · contact PI
Cardiac Inflammation in Resuscitated Hemorrhagic Shock$211,585
R01 · FY2008 · HL · contact PI
Cardiac Inflammation in Resuscitated Hemorrhagic Shock$143,982
R01 · FY2008 · HL · contact PI
Cardiac Inflammation in Resuscitated Hemorrhagic Shock$335,988
R01 · FY2007 · HL · contact PI
Cause and Consequence of TNF Overexpression in the Heart$285,308
R01 · FY2007 · HL · contact PI
Cardiac Inflammation in Resuscitated Hemorrhagic Shock$366,188
R01 · FY2006 · HL · contact PI
Cause and Consequence of TNF Overexpression in the Heart$293,829
R01 · FY2006 · HL · contact PI
Cardiac Inflammation in Resuscitated Hemorrhagic Shock$362,020
R01 · FY2005 · HL
Cause and Consequence of TNF Overexpression in the Heart$300,900
R01 · FY2005 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,546,627
P50 · FY2004 · HL
Cause and Consequence of TNF Overexpression in the Heart$300,900
R01 · FY2004 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,566,175
P50 · FY2003 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,576,475
P50 · FY2002 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$478,278
P50 · FY2002 · HL
Cytoprotective cytokine signaling and reperfusion injury$313,975
P01 · FY2002 · HL
Cytoprotective cytokine signaling and reperfusion injury$313,975
P01 · FY2002 · HL
GENES THAT CONTROL CELL NUMBER--CARDIAC TNF &APOPTOSIS$244,118
R01 · FY2002 · HL
Clinical significance of TNF alpha/RAS cross-talk in the failing heart$184,963
P50 · FY2002 · HL
Clinical significance of TNF alpha/RAS cross-talk in the failing heart$184,963
P50 · FY2002 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE$1,509,049
P50 · FY2001 · HL
Cytoprotective cytokine signaling and reperfusion injury$313,975
P01 · FY2001 · HL
GENES THAT CONTROL CELL NUMBER--CARDIAC TNF &APOPTOSIS$253,478
R01 · FY2001 · HL
Clinical significance of TNF alpha/RAS cross-talk in the failing heart$184,963
P50 · FY2001 · HL
Cytoprotective cytokine signaling and reperfusion injury$313,975
P01 · FY2000 · HL
GENES THAT CONTROL CELL NUMBER--CARDIAC TNF &APOPTOSIS$255,330
R01 · FY2000 · HL
CAUSE AND CONSEQUENCE OF TNF OVEREXPRESSION IN THE HEART$194,083
R01 · FY2000 · HL
Clinical significance of TNF alpha/RAS cross-talk in the failing heart$184,963
P50 · FY2000 · HL